Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 397,414 | 408,976 | 470,166 | 396,279 | 360,981 |
| Receivables | 229,823 | 223,542 | 225,532 | 218,184 | 179,143 |
| Inventories | 323,618 | 328,049 | 310,117 | 307,839 | 358,756 |
| Other current assets | 0 | 0 | 162,105 | 159,977 | 0 |
| TOTAL | $1,032,382 | $1,039,075 | $1,237,202 | $1,152,096 | $966,222 |
| Non-Current Assets | |||||
| PPE Net | 295,759 | 296,193 | 287,529 | 294,439 | 334,334 |
| Intangibles | 2,194,522 | 2,203,753 | 1,921,803 | 1,893,241 | 1,954,893 |
| Other Non-Current Assets | 190,124 | 202,533 | 168,602 | 113,745 | 136,310 |
| TOTAL | $2,680,405 | $2,702,479 | $2,377,934 | $2,301,425 | $2,425,537 |
| Total Assets | $3,712,787 | $3,741,554 | $3,615,136 | $3,453,521 | $3,391,759 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 110,900 | 112,500 | N/A | N/A |
| Accounts payable and accrued liabilities | 65,512 | 61,500 | 54,608 | 50,254 | 58,291 |
| Accrued Expenses | 171,255 | 161,901 | 170,311 | 152,650 | 125,004 |
| Other current liabilities | 5,890 | 5,400 | 17,026 | 17,224 | 4,717 |
| TOTAL | $318,756 | $412,301 | $401,013 | $255,146 | $212,415 |
| Non-Current Liabilities | |||||
| Long Term Debt | 935,708 | 922,672 | 933,387 | 1,036,402 | 1,076,017 |
| Other Non-Current Liabilities | 819,895 | 811,968 | 749,679 | 736,206 | 732,971 |
| TOTAL | $1,819,050 | $1,799,922 | $1,699,256 | $1,800,388 | $1,830,248 |
| Total Liabilities | $2,137,806 | $2,212,223 | $2,100,269 | $2,055,534 | $2,042,663 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,580 | 84,549 | 84,370 | 84,273 | 84,271 |
| Common Shares | 895 | 894 | 893 | 892 | 892 |
| Retained earnings | 609,955 | 574,888 | 532,265 | 439,521 | 407,184 |
| Other shareholders' equity | -50,424 | -44,088 | -74,200 | -92,137 | -103,350 |
| TOTAL | $1,574,981 | $1,529,331 | $1,514,867 | $1,397,987 | $1,349,096 |
| Total Liabilities And Equity | $3,712,787 | $3,741,554 | $3,615,136 | $3,453,521 | $3,391,759 |